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Adult brain function and behavior are influenced by
neuronal network formation during development.
Genetic susceptibility factors for adult psychiatric
illnesses, such as Neuregulin-1 and Disrupted-in-
Schizophrenia-1 (DISC1), influence adult high brain
functions, including cognition and information pro-
cessing. These factors have roles during neuro-
development and are likely to cooperate, forming
pathways or ‘‘signalosomes.’’ Here we report the
potential to generate an animal model via in utero
gene transfer in order to address an important ques-
tion of how nonlethal deficits in early development
may affect postnatal brain maturation and high brain
functions in adulthood, which are impaired in various
psychiatric illnesses such as schizophrenia. We
show that transient knockdown of DISC1 in the pre-
and perinatal stages, specifically in a lineage of pyra-
midal neurons mainly in the prefrontal cortex, leads
to selective abnormalities in postnatal mesocortical
dopaminergic maturation and behavioral abnormali-
ties associated with disturbed cortical neurocircuitry
after puberty.
INTRODUCTION
Adult brain function and behavior are influenced by neuronal
network formation during development. Consequently, distur-
bances of brain development are suggested to underlie the
pathology of adult mental disorders, such as schizophrenia and480 Neuron 65, 480–489, February 25, 2010 ª2010 Elsevier Inc.mood disorders (Lewis and Levitt, 2002; Rapoport et al., 2005;
Savitz and Drevets, 2009; Tenyi et al., 2009). Consistent with
this notion, genetic susceptibility factors for these disorders
that have been recently identified, including Neuregulin-1 and
Disrupted-in-Schizophrenia-1 (DISC1), have roles during neuro-
development and are likely to cooperate, forming molecular
‘‘pathways’’ (Harrison and Weinberger, 2005; Jaaro-Peled
et al., 2009; Owen et al., 2005). Furthermore, many studies have
indicated that variations of these disease susceptibility genes
influence high brain functions, including cognition and informa-
tion processing, in both normal subjects and patients (Ke´ri,
2009; Krug et al., 2008; Tomppo et al., 2009). Thus, these genetic
factors are believed to be good probes to explore mechanistic
links between brain development and adult brain functions.
Schizophrenia is a debilitating disorder with onset in young
adulthood, although many lines of evidence have indicated
that pre- and perinatal brain disturbances underlie the initial risks
for the disease (Buka and Fan, 1999; McNeil, 1995). It is possible
that these initial risks may in turn affect postnatal brain matura-
tion, resulting in the delayed onset of the disorder. Prodromal
stages of schizophrenia in adolescence and young adulthood
may reflect the dynamic pathophysiology of disturbed brain
maturation (Cannon et al., 2003; Jaaro-Peled et al., 2009; White
et al., 2006). Some excellent longitudinal studies with clinical
subjects have attempted to address this question (White et al.,
2006). Nonetheless, good animal models that can depict the
sequential changes from the initial disturbances in early brain
development to defects of postnatal brain maturation, leading
to adult brain dysfunction associated with schizophrenia, are
awaited to permit dissection and understanding of the molecular
mechanisms during the course of disease progression. Mice
with manipulations of genetic susceptibility factors for the
disease may provide this opportunity (Chen et al., 2006). Once
available, such models may shed light on the pathological
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Figure 1. Selective Targeting of Constructs
to Cells in a Lineage of Pyramidal Neurons
in the Prefrontal Cortex via In Utero Gene
Transfer
(A) Schematic representation of bilateral in utero
injection of constructs followed by their incorpora-
tion by electroporation into progenitor cells in the
ventricular zone at embryonic day 14 (E14).
Migrating cells with GFP are visualized at E18 after
injection of a GFP expression construct.
(B) Representative coronal and sagittal images of
brains with GFP expression at P56 after injection
of a GFP expression construct at E14. Blue,
nucleus. The scale bars represent 1 mm.
(C) GFP-positive neurons in layers II/III at postnatal
day 56 (P56) inmPFC.Most cells with GFP expres-
sion are CaMKII-positive pyramidal neurons (red
in left panels), but not GABA (red in middle panels)
or GFAP positive (red in right panels) at P56. The
scale bar represents 100 mm.
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DISC1 Knockdown via In Utero Gene Transfermechanisms for schizophrenia. Furthermore, even more impor-
tantly, these models may clarify how minor or nonlethal brain
disturbances in early development, possibly related to a combi-
nation of genetic variations, may affect high brain functions in
adults, including cognition and information processing, in a
wide range of mental conditions and even in subjects who may
not be classified as having psychiatric disorders as defined by
the Diagnostic and Statistical Manual of Mental Disorders.Neuron 65, 480–489,Here we provide evidence to support
the feasibility of in utero gene transfer to
produce mouse models to address this
question. In the present study, by utilizing
this technique, we generated mice in
which selective knockdown of DISC1 is
achieved in a lineage for pyramidal
neurons mainly in the prefrontal cortex
(PFC), but only during development,
which leads to maturation-dependent
deficits in mesocortical dopaminergic
projections and associated behavioral
changes, including those in information
processing and cognition.
RESULTS
Application of In Utero Gene
Transfer to Modulate Expression
of Target Genes in the Prefrontal
Cortex
To evaluate the feasibility of the in utero
gene transfer technique to analyze the
modulationof geneexpression in thePFC,
an expression construct of green fluores-
cent protein (GFP) was injected into bilat-
eral lateral ventricles and incorporated
by electroporation into progenitor cells in
the ventricular zone at embryonic day 14(E14) in mice (Figure 1A; see Figure S1A available online). We
analyzed sagittal and serial coronal sections from six randomly
selected brains at postnatal day 56 (P56), and found that GFP-
positive cells were located at +2.34 mm to +0.98 mm relative
to Bregma, especially in the dorsolateral prefrontal cortex
(DLPFC), medial prefrontal cortex (mPFC), orbitofrontal cortex
(OFC), and anterior cingulate cortex (Figures 1B, S1B, and
S1C). Thus, this method allows for gene targeting mainly intoFebruary 25, 2010 ª2010 Elsevier Inc. 481
DISC1
Merge
Con
P2 P14
0
0.5
1
1.5 *
R
el
at
iv
e 
In
te
ns
ity
of
 D
IS
C
1KD Con KD
P2
0
0.5
1
1.5
R
el
at
iv
e 
In
te
ns
ity
of
 D
IS
C
1
P14
I
IV
V
Vl
ll/lll
GFP
I
IV
V
Vl
ll/lll
C
on
K
D
P14
PI Merge TUNEL
B
A
P14
Con KD
C
0
0.5
1
G
FP
 in
te
ns
ity
 ra
tio
P
ro
ce
ss
es
/to
ta
l *
noC DK
-80
-40
0
R
es
tin
g 
po
te
nt
ia
l
(m
V
)
0
400
800
M
em
br
an
e 
re
si
st
an
ce
(M
Ω
)
0
20
40
M
em
br
an
e 
ca
pa
ci
ta
nc
e
(p
F)
D
noC DK
noC DK noC DK
**
I
IV
ll/lll
I
IV
ll/lll
P14
noC DK
noC DK
P14
Figure 2. Mice with Knockdown of DISC1 in
Pyramidal Neurons of the Prefrontal Cortex
during Early Development via In Utero
Gene Transfer Display Dendritic Abnormali-
ties at P14
(A) Suppression of DISC1 immunoreactivity (red)
in GFP-positive neurons is observed at P2, but
not at P14, when shRNA to DISC1 is introduced
(DISC1 knockdown [KD]) at E14 (*p < 0.05). A total
of 30 GFP-positive cells from cortical slices of
three DISC1 KD mice and those of three con-
trol mice with scrambled/control shRNA was
analyzed and compared. The scale bar represents
10 mm.
(B) GFP-positive neurons with RNAi at layers II/III
at P14 after injection at E14. KD mice display
dendritic pathology without signs of apoptosis
(TUNEL), consistent with our previous publication
(Kamiya et al., 2005). Red, nucleus. The scale bar
represents 100 mm.
(C) Reduction of GFP fluorescence intensity in
dendrites relative to total GFP fluorescence inten-
sity inmPFC of KDmice at P14, compared to those
of Con mice (*p < 0.05, n = 5 per condition), sug-
gesting impaired dendritic formation in KD mice.
Red, nucleus. The scale bar represents 50 mm.
(D) Electrophysiological characteristics of pyra-
midal neurons with knockdown of DISC1 (majority
of green cells) at layers II/III in mPFC at P14.
Membrane resistance at 80 mV and membrane
capacitance of GFP-positive neurons in DISC1
KD mice are significantly different compared with
those in Con mice (*p < 0.05), whereas there is
no difference in resting potential in these two
groups (n = 5 per condition).
Data are expressed as mean ± SEM.
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DISC1 Knockdown via In Utero Gene Transferthe PFC. In the developing cerebral cortex, pyramidal neurons
migrate radially from the ventricular zone, whereas interneurons
migrate tangentially from ganglionic eminence into the devel-
oping cerebral wall (Anderson et al., 1997;Marin andRubenstein,
2003). Glial lineages originating from the subventricular zone
are produced at late embryonic and early postnatal days (E17
to P14) (Sauvageot and Stiles, 2002). Therefore, the constructs
are likely to be integrated into cells in a lineage of pyramidal
neurons. Indeed, GFP-positive cells were confined only to pyra-
midal neurons, around 20% of which were GFP positive in layers
II/III at P56 (Figure 1C). These results indicate that in utero gene
transfer can be used for modulating target gene expression
mainly in pyramidal neurons in PFC during brain development.
Transient Knockdown of DISC1 in PFC during
Development via In Utero RNAi Transfer
In this study, we used DISC1 as a probe to address how molec-
ular disturbance in cells of the pyramidal neuron lineage in PFC
during early development might influence postnatal brain matu-
ration and adult phenotypes. Thus, we injected a well-character-
ized DISC1 short-hairpin RNA (shRNA) together with a GFP482 Neuron 65, 480–489, February 25, 2010 ª2010 Elsevier Inc.expression construct at E14 according to the protocol described
above, and confirmed targeting to PFC. Histological phenotypes
in the developing cortex elicited by this shRNA (defects in
neuronal progenitor proliferation, delay in neuronal migration,
and resultant changes in arborization) are consistent with those
elicited by other shRNAs to DISC1 thus far reported (Kamiya
et al., 2005; Mao et al., 2009), and are rescued by overexpres-
sion of wild-type DISC1 (DISC1R) (Figure S2A). Suppression of
DISC1 seems to be transient, confirmed by knockdown of
DISC1 for at least 7 days after injection, but not after 3 weeks
(Figure 2A). In the present study, we have characterized the
DISC1 knockdown-elicited phenotypic changes at P14 in
greater detail, by extending our previous observation (Kamiya
et al., 2005). As the result of the transient knockdown of DISC1
via RNA interference (RNAi) (designated DISC1 KD in this manu-
script), GFP-positive pyramidal neurons were found in layers
II/III without signs of apoptosis and with abnormal dendritic
morphology (Figures 2B, 2C, and S2B–S2D). Impaired dendritic
development in layers II/III at P14 in DISC1 KD mice was also
functionally confirmed by electrophysiological approaches
(Figure 2D).
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Figure 3. Disturbance in Postnatal Matura-
tion of Mesocortical Dopaminergic Projec-
tions to the Medial Prefrontal Cortex in
DISC1 Knockdown Mice
(A) Basal levels of extracellular dopamine (DA) in
mPFC were analyzed by in vivo microdialysis, and
a decrease in DISC1 KD mice compared with that
in Con mice was detected at P56, but not at P28
(*p < 0.05, n = 6 per condition).
(B) Monoamine content in the frontal cortex as
measured by HPLC. The level of DA in FC is
decreased in DISC1 KD mice compared with that
in Con mice at P56, but not at P28 (*p < 0.05, n = 7
per condition). No difference in the levels of NE and
5-HT is observed at these two time points.
(C) Immunostaining of tyrosine hydroxylase (TH) in
mPFC, including prelimbic and infralimbic cortex
(upper panels, low magnification; bottom panels,
high magnification). TH level in mPFC is relatively
decreased in KD mice compared with Con mice at
P56 (*p < 0.05, n = 6 per condition) in both layers
II/III and V/VI, whereas there is no difference
between KD and Con at P28 and P42. The scale
bar in low-magnification pictures represents
200 mm, and in high-magnification pictures repre-
sents 500 mm.
Data are expressed as mean ± SEM.
Neuron
DISC1 Knockdown via In Utero Gene TransferDisturbance in Postnatal Maturation of Mesocortical
Dopaminergic Projections and Interneurons to the
Medial Prefrontal Cortex in DISC1 KD Mice
Next, we addressed whether the dendritic abnormalities at
P14 elicited by transient knockdown of DISC1 in the pre-/
perinatal stages may later influence postnatal brain maturation.
We first examined differences in body weight between DISC1
KD and control mice at P14, P28, and P56, which may reflect
atypical developmental trajectories and could potentially
affect maturation of neuronal circuits and behavior nonspecif-
ically, but no difference in body weight was observed between
these two groups (Figure S3A). At the histological level, we did
not find any robust differences in Nissl staining in mPFC at
P28 and P56 (Figure S3B). No difference between DISC1 KD
and controls in immunostaining and western blotting for glial
fibrillary acidic protein (GFAP) indicated that there was no
gliosis in DISC1 KD mice at P28 and P56 (Figures S3C and
S3D).Neuron 65, 480–489In contrast, we observed a marked
decrease in the extracellular levels of
dopamine in mPFC, measured by micro-
dialysis, and total content of dopamine
between KD and controls in FC at P56 but
not at P28 (Figures 3A and 3B), whereas no
changes were observed in total content of
dopamine in other brain areas including
nucleus accumbens, hippocampus, and
cerebellum (Figure S3E). This change may
be specific to dopamine, as no changes
in glutamate, norepinephrine (NE), or sero-
tonin were observed (Figure 3B, S3E, andS3F). Increase in the level of dopamine from birth to adolescence
in the frontal cortex is known to reflect physiological maturation
of the dopaminergic projection (Benes et al., 2000; Goto and
Grace, 2007; Rosenberg and Lewis, 1995). Insufficient elevation
of dopamine at P56 in DISC1 KD mice may indicate disturbed
maturation of dopaminergic neurons. Consistent with this idea,
relative immunoreactivity against tyrosine hydroxylase (TH), a
marker of mature axon terminals of the dopaminergic projection,
was decreased in both layers II/III and V/VI at P56, but not at P28
and P42, in DISC1 KD compared to control mice (Figure 3C). This
relative decrease of TH was also confirmed by western blotting
(Figure S3G). In contrast, we did not observe changes in expres-
sion of dopamine receptor-1 (D1R) and -2 (D2R) (Figures S3G
and S3H).
Given that there are inter- and intralaminar connections of
pyramidal neurons and GABAergic interneurons in local circuits
in PFC where mesocortical dopaminergic neurons also have
synaptic contact (Sesack et al., 2003), this aberrant development, February 25, 2010 ª2010 Elsevier Inc. 483
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Figure 4. Disturbances of Interneurons and Pyra-
midal Neurons in PFC of DISC1 KD Mice after
Puberty
(A) Immunostaining of parvalbumin (PV) in the mPFC
(upper panels, low magnification; bottom panels, high
magnification). Immunoreactivity of PV is quantified under
each condition (lower graphs). The expression levels of PV
in the mPFC (both layers II/III and V/VI) are decreased in
KD mice compared with Con mice at P56, but not at P28
(*p < 0.05, n = 6 per condition). The scale bar in low-magni-
fication pictures represents 200 mm, and in high-magnifi-
cation pictures represents 500 mm.
(B) Electrophysiological responses of PFC pyramidal
neurons to electrical stimulation recorded using the
whole-cell patch-clamp technique in acute slices from
young adult male mice. Overlay of membrane potential
responses evoked with electrical stimulation of cortico-
cortical fibers before (black trace) and during (red trace)
bath application of the D2 dopamine agonist quinpirole
(5 mM) in KD and Con mice. Arrows indicate times of
single-pulse stimulation. Quinpirole attenuation of evoked
excitatory postsynaptic potentials is reduced in KD mice
(*p < 0.05, n = 5 per condition).
Data are expressed as mean ± SEM.
Neuron
DISC1 Knockdown via In Utero Gene Transferof the pyramidal neurons may affect GABAergic interneurons. To
test this possibility, we examined the expression level of parval-
bumin, a marker of the fast-spiking GABAergic interneurons. We
observed reduction of parvalbumin immunoreactivity in layers
II/III and V/VI in mPFC in DISC1 KD mice at P56 but not at P28,
suggesting that there is a possible deficit of interneurons in
adulthood; this effect is likely to occur during postnatal brain
maturation (Figure 4A). To test whether dopamine regulation of
local circuit processing in mPFC is altered in adult DISC1 KD
mice, we recorded deep-layer pyramidal neurons by using the
whole-cell patch-clamp technique in acute brain slices (Fig-
ure S4). Neither resting membrane potential nor input resistance
was different from controls, indicating that basic somatic elec-
trophysiological properties are not grossly disrupted in adult484 Neuron 65, 480–489, February 25, 2010 ª2010 Elsevier Inc.DISC1 KD mice (data not shown). Nonetheless,
bath application of the D2R dopamine receptor
agonist quinpirole attenuated electrically
evoked membrane responses in control mice,
but such attenuation was markedly reduced in
DISC1 KD mice (Figure 4B). Taken together,
these results suggest that neonatal pyramidal
neuron deficits elicited by pre-/perinatal knock-
down of DISC1 lead to overall disturbances in
circuitry involving dopamine neurons, pyramidal
neurons, and interneurons, manifested only
after puberty.
Behavioral Deficits in DISC1 KD Mice
after Puberty
We then questioned whether such neurochem-
ical and physiological disturbance in postnatal
brain maturation might result in behavioral defi-
cits. Prepulse inhibition (PPI) reflects sensorygating function, a major indicator of information processing
involving the cortex, which is also frequently impaired in various
mental illnesses (Arguello and Gogos, 2006). DISC1 KD mice at
P56, but not at P28, displayed decreased PPI, in comparison
with controls (Figure 5A). DISC1-associated PPI deficits are
further confirmed in mice by another shRNA to DISC1 that
knocks down this molecule to a lesser extent than does the
shRNA mainly used in this study (Kamiya et al., 2005, 2008;
Mao et al., 2009): milder deficits in PPI that were consistent
with the milder effect on DISC1 expression were observed in the
mice (Figure S5A). We also tested the effect of clozapine, which
is reported to elevate dopamine levels via blocking the D2 auto-
receptor (Rayevsky et al., 1995). Very interestingly, when we
administered clozapine acutely to DISC1 KD mice, we observed
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Figure 5. Attenuation of Prepulse Inhibition Deficits by Treatment
with Clozapine in DISC1 KD Mice after Puberty
(A) Performance in prepulse inhibition (PPI) at P28 and P56. Impairment
of PPI is observed in DISC1 KD mice at P56, but not at P28 (*p < 0.05,
**p < 0.01, n = 12 per condition).
(B) Effect of clozapine (CLZ) on the impairment of PPI in KDmice at P56. Treat-
ment with CLZ (3 mg/kg, i.p.) ameliorates the impairment of PPI in KD mice at
P56 (*p < 0.05, **p < 0.01, n = 16 per condition). VEH, vehicle.
(C) Effect of CLZ on extracellular DA levels in mPFC by in vivo microdialysis.
Administration of CLZ (3 mg/kg, i.p.) elevates extracellular DA levels in
mPFC in both Con and KD mice at P56 (*p < 0.05, n = 4 per condition).
Data are expressed as mean ± SEM.
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DISC1 Knockdown via In Utero Gene Transfernormalized levels of dopamine in mPFC and improvement of PPI
deficits, without alterations in the startle amplitude (Figures 5B,
5C, S5B, and S5C). These results suggest that PPI deficits in
DISC1 KD mice are, at least in part, associated with decreased
levels of dopamine in the mPFC at P56.
The novel object recognition task (NORT) measures functions
of the hippocampus and the cortex, including functions associ-ated with visual working memory (Ozawa et al., 2006). No differ-
ence was observed in exploratory preference during the training
between control and KD mice, suggesting that there were no
significant differences in curiosity and/or motivation to explore
objects between the two groups (Figure S5D). In contrast, KD
mice at P56, but not at P28, displayed impaired performance
in the test runs 24 hr after the training session, whereas no differ-
ence was found 1 hr after the training session (Figures S5D and
S5E). Acute administration of clozapine improved their perfor-
mance in NORT (Figure S5F). To address a function more
specific to the cortex, mice were assessed by a T maze test at
P56. DISC1 KD mice showed significantly fewer correct choices
than did control mice, with delay intervals of 15 s, although there
was no difference in required training time between the two
groups (Figure S5G). In contrast, no difference was observed
between DISC1 KD and control mice in the forced-swim test,
a paradigm associated with depression (Figure S5H).
Next, in order to examine dopamine-associated behavioral
deficits in DISC1 KDmice further, we challenged DISC1 KDmice
with the psychostimulant methamphetamine. Although DISC1
KD mice did not differ from controls in spontaneous locomotion
in the open field (Figure S6), DISC1 KD mice at P56, but not at
P28, displayed hypersensitivity to administration of metham-
phetamine in locomotion (Figure 6A). Consistent with this result,
we found that the increase of extracellular dopamine levels in
nucleus accumbens in DISC1 KD mice was higher than that in
controls after the administration of methamphetamine, although
the basal levels of extracellular dopamine were slightly lower in
DISC1 KD mice than in controls (Figure 6B).
DISCUSSION
There are two major conclusions in the present study. First, we
report the potential to generate an animal model via in utero
gene transfer in order to address an important question of how
nonlethal deficits in early development may affect postnatal
brain maturation of information processing and cognition in
adulthood. Second, we show that transient knockdown of
DISC1 in the pre- and perinatal stages, specifically in a lineage
of pyramidal neurons mainly in PFC, leads to abnormalities in
postnatal mesocortical dopaminergic maturation which results
in overall disturbance in circuitry and several behavioral abnor-
malities in adulthood. Although there is precedence that insults
in early development lead to delayed phenotypic manifestations
in rodents (Koshibu et al., 2005; Lipska et al., 1993; Moore et al.,
2006), the present study indicates the sequential link among
pre-/perinatal disturbance in a specific genetic susceptibility
factor (DISC1), the associated dendritic abnormalities in the
neonatal stage, and, in turn, selective phenotypes in adoles-
cence and adulthood.
This study may aid molecular understanding of how initial
insults during early development disturb postnatal brain matura-
tion for many years which results in full-blown onset of schizo-
phrenia after puberty (Buka and Fan, 1999; Jaaro-Peled et al.,
2009; McNeil, 1995). Although it is still being debated, brains
from patients with schizophrenia show abnormalities in the
cortex, especially in layers II/III, which include decreased arbori-
zation and smaller size of pyramidal neurons, aswell as alterationNeuron 65, 480–489, February 25, 2010 ª2010 Elsevier Inc. 485
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Figure 6. Hypersensitivity to the Psychostimulant
Methamphetamine in DISC1 KDMice after Puberty
(A) Methamphetamine (METH; 1 mg/kg, s.c.) -induced
hyperactivity is augmented in DISC1 KD mice compared
with Con mice, at P56 but not at P28 (*p < 0.05, n = 6–10
per condition).
(B) The extent of increase after METH challenge in levels of
extracellular DA relative to those at the baseline is
augmented in the nucleus accumbens (NAc) of DISC1
KD mice compared with Con mice at P56 (*p < 0.05,
n = 8 per condition) (right), whereas mild but significant
reduction of basal levels of extracellular DA is observed
in KD mice (**p < 0.01, n = 8 per condition) (left).
Data are expressed as mean ± SEM.
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DISC1 Knockdown via In Utero Gene Transferin a subset of interneurons (Akbarian et al., 1995; Benes and Ber-
retta, 2001; Glantz and Lewis, 2000; Guidotti et al., 2000; Lewis
et al., 2005; Selemon and Goldman-Rakic, 1999). Furthermore,
a decrease in tyrosine hydroxylase staining in schizophrenia
patients has been reported, suggesting a reduction of dopami-
nergic innervation in the prefrontal cortex in schizophrenia (Akil
et al., 1999). Primary defects for these cytoarchitectural changes
may occur during neurodevelopment, because they are not
accompanied by gliosis. Nevertheless, it has been unclear what
kindsof neurodevelopmental defects result in suchbrainanatom-
ical changes in patients with schizophrenia, with clinical onset
15–30 years after birth, characterized by psychosis and impaired
cognition and information processing, and associated with aber-
rant neurotransmission, especially dopaminergic neurotransmis-
sion. The model in this study represents a majority of these
objective characteristics reported in schizophrenia research.
Therefore, to address the hierarchy and mechanistic links of
these characteristics, this DISC1 model produced via in utero
gene transfer may be useful. For example, an important question
for futuremechanistic studieswith thismodel is howadecrease in
tyrosine hydroxylase in all layers, or disturbance of postnatal
maturation of mesocortical dopaminergic projections, is induced
by dendritic abnormalities of the pyramidal neurons in layer II/III in
the cortex in early development. Another question is how
dysfunction of mesocortical dopaminergic projection affects its
mesolimbic circuitry, including possible changes in dynamics of
dopamine uptake and release, in the nucleus accumbens.
Although various types of genetically engineered animals,
including inducible and conditional systems, have been devel-
oped, the in utero gene transfer technique with expression
and/or shRNA constructs for RNAi may be a promising alterna-486 Neuron 65, 480–489, February 25, 2010 ª2010 Elsevier Inc.tive methodology. We can select the target cell
populations for genetic modulation specifically,
by changing the direction of the electroporation
(LoTurco et al., 2009). Thus, preferential
targeting to a lineage of interneurons in the
cortex or to hippocampal neurons is also techni-
cally feasible by targeting the electrodes toward
ganglionic eminence or medial regions of the
embryonic telencephalon, respectively (Borrell
et al., 2005; Navarro-Quiroga et al., 2007).Furthermore, introduction of inducible expression constructs in
in utero gene transfer will allow us to have better control of target
gene expression (LoTurco et al., 2009; Manent et al., 2009; Mat-
suda and Cepko, 2007).
Many investigators have considered the possibility that adult
brain function and behavior are influenced by neuronal network
formation during development (Cannon et al., 2003; Harrison
and Weinberger, 2005; Jaaro-Peled et al., 2009; Lisman et al.,
2008), which is modulated by a combination of several genetic
and environmental factors, and the concept of ‘‘pathway(s)’’ is
more likely to mimic the mechanisms than the effect of a single
gene product. By using the technical advantage of in utero trans-
fer in which expression ofmore than one gene can bemodified at
one time by cotransfection of expression and/or RNAi constructs
(Kamiya et al., 2008; Shu et al., 2004; Tsai et al., 2005; Young-
Pearse et al., 2007), we will be able to test the synergistic influ-
ence or epistatic effect of multiple genetic factors. In a more
general application, we propose that this method is useful in
testing how modest but significant defects in neuronal network
formation in early development lead to adult behavioral traits;
furthermore, if potential variation between batches and animals
is well controlled, this technique may also be utilized in trying
to build novel animal models for various adult mental disorders,
including schizophrenia, in which multiple risk factors play etio-
logical roles during neurodevelopment.EXPERIMENTAL PROCEDURES
Constructs
Short-hairpin RNA (shRNA) to DISC1 (50-GGCAAACACTGTGAAGTGC-30) was
expressed by an H1 promoter-driven pSuper plasmid (Brummelkamp et al.,
Neuron
DISC1 Knockdown via In Utero Gene Transfer2002). This shRNA was shown to effectively knock down DISC1 in cell cultures
and in vivo via in utero gene transfer in previous publications from more than
one research group (Kamiya et al., 2005, 2008; Mao et al., 2009). The duration
of knockdown expression of genes by this H1-driven pSuper plasmid is
dependent on the targetmolecules that we have tested so far (data not shown),
and suppression of DISC1 was clearly transient in the developing cortex.
Scrambled target sequence without homology to any known messenger
RNA was used to produce the control RNAi. The expression construct used
for rescue control experiments (DISC1R) is described in Supplemental Infor-
mation. The GFP expression construct is under the control of the CAG
promoter.In Utero Electroporation
In utero electroporation was performed by our published protocol with some
modifications (Kamiya et al., 2005; Tabata and Nakajima, 2001). We used
ICR mice, because neuropathological changes induced by the same shRNA
to DISC1 had been characterized in this strain (Kamiya et al., 2005, 2008).
Pregnant mice were anesthetized at E14 by intraperitoneal administration of
2,2,2-tribromoethanol in tert-amyl alcohol (0.4 mg/g). Two centimeter midline
laparotomy was performed and the uterine horn was exposed. RNAi plasmids
(2 mg/ml) together with GFP expression vector with CAG promoter (1 mg/ml)
(molar ratio approximately 3:1) were injected into the bilateral ventricles with
a glass micropipette made from a microcapillary tube (GD-1; Narishige).
Injected plasmid solution contained Fast Green solution (0.001%) to monitor
the injection. The embryo’s head in the uterus was held between the twee-
zers-type electrode consisting of two disc electrodes of 5 mm diameter
(CUY650-5; Tokiwa Science). Depending on which hemisphere was injected,
the electrodes were oriented at a rough 20 outward angle from the midline
and a rough 30 angle downward from an imaginary line from the olfactory
bulbs to the caudal side of the cortical hemisphere. Electrode pulses (35V;
50 ms) were charged five times at intervals of 950 ms with an electroporator
(CUY21E; Tokiwa Science). The uterine horn was placed back into the
abdominal cavity and the abdominal wall and skin were sutured. All experi-
ments were performed in accordance with the institutional guidelines for
animal experiments.Histology and Quantitative Analyses
Histological procedures were performed as previously described (Kamiya
et al., 2005) withminormodifications. Brainswere fixedwith 4%paraformalde-
hyde, and coronal sections, including mPFC, were obtained with a cryostat at
20 mm (CM1850; Leica). For immunohistochemistry, the following primary anti-
bodieswere used: anti-DISC1 (1: 100) (Ozeki et al., 2003), anti-tyrosine hydrox-
ylase (TH) (1:100; Millipore), anti-parvalbumin (PV) (1:100; Sigma-Aldrich), anti-
CaMKII (1:200;UpstateBiotechnology), andanti-GABA (1:200;Sigma-Aldrich).
Fluorescent secondary antibodies conjugated to Alexa 488 and Alexa 568
(Molecular Probes) as well as biotin-conjugated secondaries were used for
chromogen detection. Nuclei were labeled with Neurotrace Nissl 530/615
(Molecular Probes), propidium iodide (Molecular Probes), or DAPI (Molecular
Probes). TUNEL staining was carried out as published (Yu et al., 2003).
To evaluate which types of cells were targeted by in utero gene transfer, the
number of double-labeled cells with GFP together with specific cell markers,
such as CaMKII (for pyramidal neurons), GABA (for interneurons), and GFAP
(for astrocytes), was counted in a region of interest defined as 100 mm wide
3 50 mm high in layers II/III in mPFC. Two regions of interest were randomly
selected from three mice (a total of six regions). Images were acquired with
a confocal microscope (LSM510; Carl Zeiss). The ratio of the number of
double-labeled cells to that of cells with each cell marker was measured.
In order to quantify the effect of RNAi on expression of DISC1, the immuno-
fluorescent intensity of DISC1 signal in each GFP-positive cell was measured
by using MetaMorph software version 7.1 (MDS Analytical Technologies) after
images were acquired with a confocal microscope (LSM510). The acquisition
parameters were kept the same for all images. The intensity of the signal from
randomly selected 10 GFP-positive cells in layers II/III of mPFC was quantita-
tively assessed in three DISC1 KD and three Con mice (i.e., 30 cells from
DISC1 KD and 30 cells from Con mice). The signal in a region of equal size
without cells in the lateral ventricle was subtracted as background.To quantify immunoreactivity of TH and PV, a region of interest was defined
as 800 mmwide3 1300 mm high in mPFC in the coronal sections (anteroposte-
rior [AP]: +1.98 to +1.54mm;mediolateral (ML): ± 0.8 mm fromBregma; dorso-
ventral [DV]:1.75 to3.05mmfrom thedura) according to theatlas of Franklin
and Paxinos (2007). Three images were acquired with a light microscope
(Axioskop2 plus; Carl Zeiss) for each brain (six brains per DISC1KDand control
mice). The acquisition parameters were kept the same for all images. The areas
of TH- or PV-positive cells/mm2 were measured by the imaging software Win-
Roof (Mitani) after subtraction of the threshold value. The threshold was auto-
matically measured at a minimum level by this software in the first image from
a control mouse sample at P28 and was kept constant across all images.
For the procedures of morphological analysis of dendrites, see Supple-
mental Experimental Procedures.
Microdialysis
Microdialysis was carried out as previously described (Niwa et al., 2007) with
a minor modification. A guide cannula (AG-6; Eicom) was implanted into
the mPFC (15 angle from AP: +1.7 mm; ML: 1.0 mm from Bregma; DV:
1.5 mm from the dura) or nucleus accumbens (AP: +1.7 mm; ML: 0.8 mm
from Bregma; DV: 4.0 mm from the dura). Ringer’s solution (147 mM NaCl,
4mMKCl, and 2.3mMCaCl2) was continuously perfused (1.0 ml/min). The dial-
ysates were collected every 10 min and analyzed by high-performance liquid
chromatography (HPLC) (Eicom). The levels of dopamine were also analyzed
after the intraperitoneal injection of clozapine (3 mg/kg) (Sigma-Aldrich) or
subcutaneous injection of methamphetamine (METH) (1 mg/kg) (Dainippon
Sumitomo).
High-Performance Liquid Chromatography
Brains were removed rapidly, and each brain region was dissected out on ice
according to the atlas of Franklin and Paxinos (2007). The brain homogenates
were centrifuged at 20,000 3 g for 15 min at 4C, and the supernatants were
mixed with 1M sodium acetate to adjust to pH 3.0 for analysis by HPLC and by
electrochemical detector (Eicom). The contents of norepinephrine (NE), dopa-
mine (DA), and 5-hydroxytryptamine (5-HT) were determined as previously
described (Miyamoto et al., 2002).
Electrophysiology
Mice were perfused with ice-cold artificial cerebrospinal fluid (ACSF) contain-
ing 125 mM NaCl, 25 mM NaHCO3, 10 mM glucose, 3.5 mM KCl, 1.25 mM
NaH2PO4, 0.5 mM (for P14) or 0.1 mM (for adult stage) CaCl2, and 3 mM
MgCl2 (pH 7.4); osmolarity 285–295 mOsm. Coronal slices of brains at
400 mm (AP: +1.7 to 2.1 mm from Bregma) were made on a Vibratome
and incubated in ACSF solution (35C) oxygenated with 95% O2 and 5%
CO2 for 60–70 min. For the recording ACSF, CaCl2 was increased to 2 mM
and MgCl2 was decreased to 1 mM. All experiments were conducted at
33C–35C.
At P14, whole-cell recordings were performed from the GFP-labeled pyra-
midal neurons in layers II/III in the mPFC. Patch pipettes (3–6 MU) were filled
with 115 mM K gluconate, 20 mM KCl, 10 mM KOH, 2 mM MgCl2, 4 mM
Na2ATP, 1 mM NaGTP, 10 mM HEPES, 0.4 mM EGTA (pH 7.2). The tm was
obtained by single-exponential fitting and the membrane capacitance was
calculated.
At adult stage, whole-cell recordings were performed from pyramidal
neurons in layers V/VI in the mPFC, where GFP-labeled cells were located in
layers II/III, and identified under visual guidance by using infrared differential
interference contrast video microscopy. Electrical stimulation (1 pulse, 0.2–
1.4 mA) was applied through an electrode consisting of tungsten wire. The
stimulating electrode was placed near layer I, 0.7–1 mm lateral to the location
of whole-cell recordings in layers V/VI . Patch pipettes (9–12 MU) were filled
with 115 mM K gluconate, 10 mM HEPES, 2 mM MgCl2, 20 mM KCl, 2 mM
MgATP, 2 mM Na2ATP, and 0.3 mM GTP (pH 7.3); 285–295 mOsm. All bath-
applied drugs, such as quinpirole and CNQX, were applied in the recording
solution at known concentrations. Single pulses of current were delivered
every 20 s, and stimulation current was adjusted so as to produce 4–10 mV
postsynaptic potentials with reliable amplitude. Baseline responses to stimu-
lation were recorded prior to adding quinpirole (5 mM) for 5–6 min. The magni-
tude of evoked responses was averaged over the baseline and compared toNeuron 65, 480–489, February 25, 2010 ª2010 Elsevier Inc. 487
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addition. This period was chosen for consistency, with differences revealed
by previous investigations of D2 modulation of PFC activity in rodent models
of schizophrenia (Tseng et al., 2008).
Behavioral Analysis
Prepulse Inhibition
Prepulse inhibition (Arguello and Gogos, 2006) of the acoustic startle response
was measured using an SR-LAB System (San Diego Instruments). The stim-
ulus onset consisted of a 20 ms prepulse, a 100 ms delay, and then a 40 ms
startle pulse. The intensity of the prepulse was 8 or 16 dB above the 70 dB
background noise. The amount of prepulse inhibition was calculated as
a percentage of the 120 dB acoustic startle response: 100 – [(startle reactivity
on prepulse + startle pulse)/startle reactivity on startle pulse] 3 100. PPI tests
were also performed 30 min after the intraperitoneal injection of clozapine
(3 mg/kg).
Locomotor Activity
To measure spontaneous activity, mice were placed in a transparent acrylic
cage, and locomotion and rearing were measured every 5 min for 60 min by
using digital counters with infrared sensors (Scanet SV-10; Merquest) as
described previously (Miyamoto et al., 2002). To measure methamphetamine
(METH) -induced hyperactivity, mice received one subcutaneous injection
of METH (1 mg/kg) after 30 min of prehabituation in a cage (Miyamoto et al.,
2004).
Unbiased Assessment in Experimental Procedures
To avoid experimental bias by investigators, in utero surgery and all analyses,
including those for DISC1 immunostaining and behavioral tests, were con-
ducted by multiple investigators in a systematic manner as follows: an inves-
tigator conducted in utero surgery without knowing the identification of
constructs. Furthermore, investigators conducted several assays without
knowing the identification of mice (either DISC1 KD or controls).
Statistical Analysis
The Student’s t test was used in comparing two sets of data. Statistical differ-
ences amongmore than three groupswere determined using one-way analysis
of variance (ANOVA), two-way ANOVA, or ANOVA with repeated measures
followed by Bonferroni multiple comparison tests. A value of p < 0.05 was
considered statistically significant. All data are expressed as mean ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at doi:10.1016/j.neuron.
2010.01.019.
ACKNOWLEDGMENTS
We thank Dr. Pamela Talalay and Dr. Eva Anton for critical reading andMs. Yu-
kiko Lema for organizing the manuscript. This work was supported by U.S.
Public Heath Service grant MH-069853 (A.S.), Silvio O. Conte Center grants
MH-084018 (A.S.) and MH-088753 (A.S.), and foundation grants from Stanley
(A.S.), S-R (A.S., A.K.), RUSK (A.S.), and NARSAD (A.S., A.K., H.J.-P.). This
work was also supported by grants from JSPS (T.N., K.N., M.N.), MEXT
(T.N., K.N.), MARC (T.N.), MHLW (T.N., K.K.), Sumitomo (K.N.), Naito (K.N.),
Academic Frontier Project (T.N.), and Takeda (T.N., K.N.).
Accepted: January 14, 2010
Published: February 24, 2010
REFERENCES
Akbarian, S., Kim, J.J., Potkin, S.G., Hagman, J.O., Tafazzoli, A., Bunney,
W.E., Jr., and Jones, E.G. (1995). Gene expression for glutamic acid decarbox-
ylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.
Arch. Gen. Psychiatry 52, 258–266.488 Neuron 65, 480–489, February 25, 2010 ª2010 Elsevier Inc.Akil, M., Pierri, J.N., Whitehead, R.E., Edgar, C.L., Mohila, C., Sampson, A.R.,
and Lewis, D.A. (1999). Lamina-specific alterations in the dopamine innerva-
tion of the prefrontal cortex in schizophrenic subjects. Am. J. Psychiatry
156, 1580–1589.
Anderson, S.A., Eisenstat, D.D., Shi, L., and Rubenstein, J.L. (1997). Inter-
neuron migration from basal forebrain to neocortex: dependence on Dlx
genes. Science 278, 474–476.
Arguello, P.A., and Gogos, J.A. (2006). Modeling madness in mice: one piece
at a time. Neuron 52, 179–196.
Benes, F.M., and Berretta, S. (2001). GABAergic interneurons: implications for
understanding schizophrenia and bipolar disorder. Neuropsychopharmacol-
ogy 25, 1–27.
Benes, F.M., Taylor, J.B., and Cunningham, M.C. (2000). Convergence and
plasticity of monoaminergic systems in the medial prefrontal cortex during
the postnatal period: implications for the development of psychopathology.
Cereb. Cortex 10, 1014–1027.
Borrell, V., Yoshimura, Y., andCallaway, E.M. (2005). Targeted gene delivery to
telencephalic inhibitory neurons by directional in utero electroporation. J. Neu-
rosci. Methods 143, 151–158.
Brummelkamp, T.R., Bernards, R., and Agami, R. (2002). A system for stable
expression of short interfering RNAs in mammalian cells. Science 296,
550–553.
Buka, S.L., and Fan, A.P. (1999). Association of prenatal and perinatal compli-
cations with subsequent bipolar disorder and schizophrenia. Schizophr. Res.
39, 113–119.
Cannon, T.D., van Erp, T.G., Bearden, C.E., Loewy, R., Thompson, P., Toga,
A.W., Huttunen, M.O., Keshavan, M.S., Seidman, L.J., and Tsuang, M.T.
(2003). Early and late neurodevelopmental influences in the prodrome to
schizophrenia: contributions of genes, environment, and their interactions.
Schizophr. Bull. 29, 653–669.
Chen, J., Lipska, B.K., and Weinberger, D.R. (2006). Genetic mouse models of
schizophrenia: from hypothesis-based to susceptibility gene-based models.
Biol. Psychiatry 59, 1180–1188.
Franklin, B.J.K., and Paxinos, G. (2007). The Mouse Brain in Stereotaxic Coor-
dinates (San Diego: Academic Press).
Glantz, L.A., and Lewis, D.A. (2000). Decreased dendritic spine density on
prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry
57, 65–73.
Goto, Y., and Grace, A.A. (2007). The dopamine system and the pathophysi-
ology of schizophrenia: a basic science perspective. Int. Rev. Neurobiol.
78C, 41–68.
Guidotti, A., Auta, J., Davis, J.M., Di-Giorgi-Gerevini, V., Dwivedi, Y., Grayson,
D.R., Impagnatiello, F., Pandey, G., Pesold, C., Sharma, R., et al. (2000).
Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression
in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen.
Psychiatry 57, 1061–1069.
Harrison, P.J., and Weinberger, D.R. (2005). Schizophrenia genes, gene
expression, and neuropathology: on the matter of their convergence. Mol.
Psychiatry 10, 40–68.
Jaaro-Peled, H., Hayashi-Takagi, A., Seshadri, S., Kamiya, A., Brandon, N.J.,
and Sawa, A. (2009). Neurodevelopmental mechanisms of schizophrenia:
understanding disturbed postnatal brain maturation through neuregulin-1-
ErbB4 and DISC1. Trends Neurosci. 32, 485–495.
Kamiya, A., Kubo, K., Tomoda, T., Takaki, M., Youn, R., Ozeki, Y., Sawamura,
N., Park, U., Kudo, C., Okawa, M., et al. (2005). A schizophrenia-associated
mutation of DISC1 perturbs cerebral cortex development. Nat. Cell Biol. 7,
1167–1178.
Kamiya, A., Tan, P.L., Kubo, K., Engelhard, C., Ishizuka, K., Kubo, A., Tsukita,
S., Pulver, A.E., Nakajima, K., Cascella, N.G., et al. (2008). Recruitment of
PCM1 to the centrosome by the cooperative action of DISC1 and BBS4:
a candidate for psychiatric illnesses. Arch. Gen. Psychiatry 65, 996–1006.
Neuron
DISC1 Knockdown via In Utero Gene TransferKe´ri, S. (2009). Genes for psychosis and creativity: a promoter polymorphism
of the neuregulin 1 gene is related to creativity in people with high intellectual
achievement. Psychol. Sci. 20, 1070–1073.
Koshibu, K., Ahrens, E.T., and Levitt, P. (2005). Postpubertal sex differentiation
of forebrain structures and functions depend on transforming growth factor-a.
J. Neurosci. 25, 3870–3880.
Krug, A., Markov, V., Leube, D., Zerres, K., Eggermann, T., Nothen, M.M.,
Skowronek, M.H., Rietschel, M., and Kircher, T. (2008). Genetic variation in
the schizophrenia-risk gene neuregulin1 correlates with personality traits in
healthy individuals. Eur. Psychiatry 23, 344–349.
Lewis, D.A., and Levitt, P. (2002). Schizophrenia as a disorder of neurodevel-
opment. Annu. Rev. Neurosci. 25, 409–432.
Lewis, D.A., Hashimoto, T., and Volk, D.W. (2005). Cortical inhibitory neurons
and schizophrenia. Nat. Rev. Neurosci. 6, 312–324.
Lipska, B.K., Jaskiw, G.E., and Weinberger, D.R. (1993). Postpubertal emer-
gence of hyperresponsiveness to stress and to amphetamine after neonatal
excitotoxic hippocampal damage: a potential animal model of schizophrenia.
Neuropsychopharmacology 9, 67–75.
Lisman, J.E., Coyle, J.T., Green, R.W., Javitt, D.C., Benes, F.M., Heckers, S.,
and Grace, A.A. (2008). Circuit-based framework for understanding neuro-
transmitter and risk gene interactions in schizophrenia. Trends Neurosci. 31,
234–242.
LoTurco, J., Manent, J.B., and Sidiqi, F. (2009). New and improved tools for in
utero electroporation studies of developing cerebral cortex. Cereb. Cortex 19
(Suppl 1), i120–i125.
Manent, J.B., Wang, Y., Chang, Y., Paramasivam, M., and LoTurco, J.J.
(2009). Dcx reexpression reduces subcortical band heterotopia and seizure
threshold in an animal model of neuronal migration disorder. Nat. Med. 15,
84–90.
Mao, Y., Ge, X., Frank, C.L., Madison, J.M., Koehler, A.N., Doud, M.K., Tassa,
C., Berry, E.M., Soda, T., Singh, K.K., et al. (2009). Disrupted in schizophrenia 1
regulates neuronal progenitor proliferation via modulation of GSK3b/b-catenin
signaling. Cell 136, 1017–1031.
Marin, O., and Rubenstein, J.L. (2003). Cell migration in the forebrain. Annu.
Rev. Neurosci. 26, 441–483.
Matsuda, T., and Cepko, C.L. (2007). Controlled expression of transgenes
introduced by in vivo electroporation. Proc. Natl. Acad. Sci. USA 104, 1027–
1032.
McNeil, T.F. (1995). Perinatal risk factors and schizophrenia: selective review
and methodological concerns. Epidemiol. Rev. 17, 107–112.
Miyamoto, Y., Yamada, K., Noda, Y., Mori, H., Mishina, M., and Nabeshima, T.
(2002). Lower sensitivity to stress and altered monoaminergic neuronal
function in mice lacking the NMDA receptor 3 4 subunit. J. Neurosci. 22,
2335–2342.
Miyamoto, Y., Yamada, K., Nagai, T., Mori, H., Mishina, M., Furukawa, H.,
Noda, Y., and Nabeshima, T. (2004). Behavioural adaptations to addictive
drugs in mice lacking the NMDA receptor 31 subunit. Eur. J. Neurosci. 19,
151–158.
Moore, H., Jentsch, J.D., Ghajarnia, M., Geyer, M.A., and Grace, A.A. (2006).
A neurobehavioral systems analysis of adult rats exposed to methylazoxyme-
thanol acetate on E17: implications for the neuropathology of schizophrenia.
Biol. Psychiatry 60, 253–264.
Navarro-Quiroga, I., Chittajallu, R., Gallo, V., and Haydar, T.F. (2007). Long-
term, selective gene expression in developing and adult hippocampal pyra-
midal neurons using focal in utero electroporation. J. Neurosci. 27, 5007–5011.
Niwa, M., Nitta, A., Mizoguchi, H., Ito, Y., Noda, Y., Nagai, T., and Nabeshima,
T. (2007). A novel molecule ‘‘shati’’ is involved in methamphetamine-induced
hyperlocomotion, sensitization, and conditioned place preference. J. Neuro-
sci. 27, 7604–7615.Owen, M.J., Craddock, N., and O’Donovan, M.C. (2005). Schizophrenia:
genes at last? Trends Genet. 21, 518–525.
Ozawa, K., Hashimoto, K., Kishimoto, T., Shimizu, E., Ishikura, H., and Iyo, M.
(2006). Immune activation during pregnancy in mice leads to dopaminergic
hyperfunction and cognitive impairment in the offspring: a neurodevelopmental
animal model of schizophrenia. Biol. Psychiatry 59, 546–554.
Ozeki, Y., Tomoda, T., Kleiderlein, J., Kamiya, A., Bord, L., Fujii, K., Okawa, M.,
Yamada, N., Hatten, M.E., Snyder, S.H., et al. (2003). Disrupted-in-Schizo-
phrenia-1 (DISC1): mutant truncation prevents binding to NudE-like (NUDEL)
and inhibits neurite outgrowth. Proc. Natl. Acad. Sci. USA 100, 289–294.
Rapoport, J.L., Addington, A.M., Frangou, S., and Psych, M.R. (2005). The
neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry
10, 434–449.
Rayevsky, K.S., Gainetdinov, R.R., Grekhova, T.V., and Sotnikova, T.D. (1995).
Regulation of dopamine release and metabolism in rat striatum in vivo: effects
of dopamine receptor antagonists. Prog. Neuropsychopharmacol. Biol.
Psychiatry 19, 1285–1303.
Rosenberg, D.R., and Lewis, D.A. (1995). Postnatal maturation of the dopami-
nergic innervation of monkey prefrontal and motor cortices: a tyrosine hydrox-
ylase immunohistochemical analysis. J. Comp. Neurol. 358, 383–400.
Sauvageot, C.M., and Stiles, C.D. (2002). Molecular mechanisms controlling
cortical gliogenesis. Curr. Opin. Neurobiol. 12, 244–249.
Savitz, J., and Drevets, W.C. (2009). Bipolar and major depressive disorder:
neuroimaging the developmental-degenerative divide. Neurosci. Biobehav.
Rev. 33, 699–771.
Selemon, L.D., andGoldman-Rakic, P.S. (1999). The reduced neuropil hypoth-
esis: a circuit based model of schizophrenia. Biol. Psychiatry 45, 17–25.
Sesack, S.R., Carr, D.B., Omelchenko, N., and Pinto, A. (2003). Anatomical
substrates for glutamate-dopamine interactions: evidence for specificity of
connections and extrasynaptic actions. Ann. N Y Acad. Sci. 1003, 36–52.
Shu, T., Ayala, R., Nguyen, M.D., Xie, Z., Gleeson, J.G., and Tsai, L.H. (2004).
Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to
regulate cortical neuronal positioning. Neuron 44, 263–277.
Tabata, H., and Nakajima, K. (2001). Efficient in utero gene transfer system to
the developing mouse brain using electroporation: visualization of neuronal
migration in the developing cortex. Neuroscience 103, 865–872.
Tenyi, T., Trixler, M., and Csabi, G. (2009). Minor physical anomalies in affec-
tive disorders. A review of the literature. J. Affect. Disord. 112, 11–18.
Tomppo, L., Hennah, W., Miettunen, J., Jarvelin, M.R., Veijola, J., Ripatti, S.,
Lahermo, P., Lichtermann, D., Peltonen, L., and Ekelund, J. (2009). Association
of variants in DISC1 with psychosis-related traits in a large population cohort.
Arch. Gen. Psychiatry 66, 134–141.
Tsai, J.W., Chen, Y., Kriegstein, A.R., and Vallee, R.B. (2005). LIS1 RNA inter-
ference blocks neural stem cell division, morphogenesis, and motility at
multiple stages. J. Cell Biol. 170, 935–945.
Tseng, K.Y., Lewis, B.L., Hashimoto, T., Sesack, S.R., Kloc, M., Lewis, D.A.,
and O’Donnell, P. (2008). A neonatal ventral hippocampal lesion causes
functional deficits in adult prefrontal cortical interneurons. J. Neurosci. 28,
12691–12699.
White, T., Anjum, A., and Schulz, S.C. (2006). The schizophrenia prodrome.
Am. J. Psychiatry 163, 376–380.
Young-Pearse, T.L., Bai, J., Chang, R., Zheng, J.B., LoTurco, J.J., and Selkoe,
D.J. (2007). A critical function for b-amyloid precursor protein in neuronal
migration revealed by in utero RNA interference. J. Neurosci. 27, 14459–
14469.
Yu, Z.X., Li, S.H., Evans, J., Pillarisetti, A., Li, H., and Li, X.J. (2003). Mutant
huntingtin causes context-dependent neurodegeneration in mice with Hun-
tington’s disease. J. Neurosci. 23, 2193–2202.Neuron 65, 480–489, February 25, 2010 ª2010 Elsevier Inc. 489
